139 related articles for article (PubMed ID: 34919042)
1. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
Loureiro-Amigo J; Franco-Jarava C; Perurena-Prieto J; Palacio C; Martínez-Valle F; Soláns-Laqué R
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
[TBL] [Abstract][Full Text] [Related]
2. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
[TBL] [Abstract][Full Text] [Related]
3. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
[TBL] [Abstract][Full Text] [Related]
4. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
[TBL] [Abstract][Full Text] [Related]
5. Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome.
Loureiro-Amigo J; Palacio-García C; Martínez-Gallo M; Martínez-Valle F; Ramentol-Sintas M; Soláns-Laqué R
Rheumatology (Oxford); 2021 Dec; 60(12):5647-5658. PubMed ID: 33620072
[TBL] [Abstract][Full Text] [Related]
6. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
7. Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.
Barcelos F; Martins C; Papoila A; Geraldes C; Cardigos J; Nunes G; Lopes T; Alves N; Vaz-Patto J; Branco J; Borrego LM
Rheumatol Int; 2018 Jun; 38(6):1063-1073. PubMed ID: 29623391
[TBL] [Abstract][Full Text] [Related]
8. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
9. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
Deng F; Chen J; Zheng J; Chen Y; Huang R; Yin J; Gao X; Lin Q; Huang C; Gao Y; Yu X; Liu Z
Int J Rheum Dis; 2016 Jul; 19(7):715-20. PubMed ID: 25941062
[TBL] [Abstract][Full Text] [Related]
10. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
Zhu T; Pan Z; Zhang N
Clin Rheumatol; 2022 Sep; 41(9):2791-2802. PubMed ID: 35616754
[TBL] [Abstract][Full Text] [Related]
11. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
Lee SJ; Oh HJ; Choi BY; Jang YJ; Lee JY; Park JK; Song YW
J Immunol Res; 2016; 2016():5781070. PubMed ID: 28074193
[TBL] [Abstract][Full Text] [Related]
14. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
[TBL] [Abstract][Full Text] [Related]
16. Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sjögren's syndrome.
Mumcu G; Biçakçigil M; Yilmaz N; Ozay H; Karaçayli U; Cimilli H; Yavuz S
Oral Health Prev Dent; 2013; 11(3):229-34. PubMed ID: 23878841
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
19. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
20. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
